Dr. Joseph H Helm Iii, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 36500 Aurora Dr, Summit, WI 53066 Phone: 262-434-1000 |
Dr. Joel David Harris, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 36500 Aurora Dr, Summit, WI 53066 Phone: 262-434-5000 |
Dr. Dennis Frederick Zagrodnik Ii, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 36500 Aurora Dr, Summit, WI 53066 Phone: 262-434-5000 Fax: 262-434-7250 |
Andrew Roger Dodd, M.D. Surgery - Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 36500 Aurora Dr, Summit, WI 53066 Phone: 262-434-5000 |
Kathryn M Haberman, MD Surgery - Trauma Surgery Medicare: Accepting Medicare Assignments Practice Location: 36500 Aurora Dr, Summit, WI 53066 Phone: 262-434-1000 Fax: 920-434-5050 |
Peter Anthony Garza Jr., MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 36500 Aurora Dr, Summit, WI 53066 Phone: 262-434-5000 |
News Archive
A new study, published in the Journal of the American College of Cardiology, highlights the feasible use of mobile health (mHealth) devices to help with the screening and detection of a common heart condition.
A study published today in EMBO Molecular Medicine reveals that the loss of function of the gene RARRES3 in breast cancer cells promotes metastasis to the lung.
RetroSense Therapeutics, LLC, a Wayne State University start-up biotechnology company, has received the Luis Villalobos Award from the Angel Capital Association, the world's leading professional association for angel investors.
Massachusetts businesses and most of the state's health insurers on Wednesday announced the formation of the Coalition for Affordable Health Coverage, a lobbying group that will work to control rising health care costs in the state and prevent cost-shifting to employers, the Boston Globe reports.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, and Cardiogenesis Corporation, a leading developer of surgical products used in the treatment of patients with refractory angina resulting from diffuse coronary artery disease, today announced that the boards of directors of both companies have approved a definitive agreement under which CryoLife will acquire all of the outstanding shares of Cardiogenesis for $0.457 per share.
› Verified 5 days ago